Tevogen Inc. (TVGN)
TVGNNASDAQ-GMBiotechnology: Biological Products (No Diagnostic Substances)
$5.72
-0.1200 (-2.05%) today
At the close, Nov 10, 4:00 PM ET. After hours $5.72 –
- Market cap
- $388.28m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $5.72 to $5.97
- 52-week range
- $3.64 to $25.12
- Average volume
- 8,686
- Previous close
- $5.84
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$5.73m | -$4.61m | -$5.40m | -$5.66m |
| Net income | -$5.73m | -$4.68m | -$5.45m | -$5.76m |
News
8 latest- Tevogen Regains Nasdaq Listing Compliance; Stock Up RTTNews · Oct 1, 2026
- Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired RTTNews · Jul 27, 2026
- Top Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest RTTNews · May 29, 2026
- Tevogen Advances Strategic Acquisition Plans With Potential To Add $100 Million In Annual Revenue RTTNews · May 29, 2026
- Tevogen Signs LOI To Evaluate MSO Acquisition; Stock Up RTTNews · May 21, 2026
- Tevogen.AI's PredicTcell Model Nears Completion As Company Begins Commercial Readiness Work RTTNews · Apr 28, 2026
- Tevogen Bio Holdings (TVGN) Price Target Increased by 1,900.00% to 102.00Fintel · Mar 27, 2026
- Tevogen Shares Plunge 22% After Reverse Stock Split Announcement RTTNews · Mar 4, 2026
The company
Tevogen is a healthcare enterprise focused on improving the affordability and accessibility of life-saving medicines. The Company brings together three complementary efforts: Tevogen Bio, its biotechnology initiative; Tevogen.AI, its artificial intelligence and technology initiative; and Tevogen Healthcare Services, its emerging healthcare services initiative. Together, these efforts are designed to create a more integrated healthcare model in which science, technology, and operational efficiency work together to reduce the cost of medication and expand patient access.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- tevogen.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.